De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

To determine the clinical fate of patients with de novo deletion 17p13.1 (17p−) chronic lymphocytic leukemia (CLL), we retrospectively studied the outcome of 99 treatment-naive 17p− CLL patients from the M. D. Anderson Cancer Center (n = 64) and the Mayo Clinic (n = 35). Among 67 asymptomatic patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Tam, Constantine S., Shanafelt, Tait D., Wierda, William G., Abruzzo, Lynne V., Van Dyke, Daniel L., O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan A., Lynn, Alice, Kay, Neil E., Keating, Michael J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Clinical Trials and Observations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916942/
https://ncbi.nlm.nih.gov/pubmed/19414856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-210591
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki